Sigma Pharmaceuticals Ltd Price, Chart & Factor Exposure
Free Data & Analytics AccessNext earnings: Wed, Feb 24, 2027 · estimates and history
Sigma Pharmaceuticals Ltd Forecast
Sigma Pharmaceuticals Ltd short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 12.4% a year, a typical one-standard-deviation range is 2.8396–2.9404 over a week, 2.7867–2.9933 over a month and 2.5323–3.2477 over a year. (Signals as of 21 Nov 2026.)
Sigma Pharmaceuticals Ltd Price Chart
Sigma Pharmaceuticals Ltd Factors
YoY −79.4%
YoY −44.4%
YoY −11.8%
YoY −73.0%
YoY −44.2%
YoY −450.0%
YoY +384.5%
YoY +114.4%
YoY −5.6%
YoY −2.2%
YoY −72.1%
YoY −2.1%
YoY −4.1%
YoY +65.9%
YoY −8.8%
YoY +50.0%
YoY −3.3%
Sigma Pharmaceuticals Ltd fundamentals: income statement, balance sheet & cash flow
Sigma Pharmaceuticals Ltd reported revenue of 10.83bn AUD and net income of 709.2m AUD in FY2026, the year ended 31 January 2026 — revenue up 121.4% and net income up 33.8% on the prior year. Free cash flow was 517.9m AUD. These figures are as reported in the filings, not restated: 27 fiscal years and 99 quarters of history, back to January 2000.
| AUD billions | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | 31 Jan 2026 | 31 Jan 2025 | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 |
| Revenue | 10.83 | 4.89 | 3.32 | 3.66 | 3.45 |
| Cost of revenue | 8.88 | 4.56 | 3.13 | 3.44 | 3.25 |
| Gross profit | 1.96 | 0.33 | 0.19 | 0.22 | 0.20 |
| Selling, general & admin. | 0.46 | 0.38 | 0.09 | 0.08 | 0.09 |
| Operating income | 1.00 | 0.72 | -0.07 | -0.07 | -0.11 |
| EBITDA | 1.08 | 0.09 | 0.05 | 0.05 | 0.03 |
| Interest expense | 0.11 | 0.02 | 0.02 | 0.01 | 0.01 |
| Pre-tax income | 1.01 | 0.74 | 0.01 | 0.01 | -0.01 |
| Income tax | 0.30 | 0.22 | 0.00 | 0.00 | 0.00 |
| Net income | 0.71 | 0.53 | 0.00 | 0.00 | -0.01 |
Download Sigma Pharmaceuticals Ltd fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.SIG.AU&statement=all&freq=a&format=csv&years=10
Figures in AUD, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.
Research on Sigma Pharmaceuticals Ltd
Explore MacroFinance macro & markets research and analysis.
Sigma Pharmaceuticals Ltd Trading Strategies
31 backtested tactical asset allocation strategies hold EFA (developed markets outside the US), the closest tradable exposure to Sigma Pharmaceuticals Ltd; 22 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in EFA | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Butler's Elastic Asset Allocation - Defensive | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Butler's Elastic Asset Allocation - Offensive | Aggressive | Monthly | Premium · upgrade to view | |||
| Momentum Turning Points | Conservative | Monthly | Premium · upgrade to view | |||
| Keller, Butler and Kipnis' Classical Asset Allocation - Offensive | Moderate | Monthly | Premium · upgrade to view | |||
| Financial Mentor's All-Weather Quad Momentum | Aggressive | Monthly | Premium · upgrade to view | |||
| Keller, Butler and Kipnis' Classical Asset Allocation - Defensive | Moderate | Monthly | Premium · upgrade to view | |||
| Livingston's Mama Bear (Muscular Portfolios) | Aggressive | Monthly | Premium · upgrade to view | |||
| Meb Faber's Global Tactical Asset Allocation 13 (GTAA 13) | Conservative | Monthly | Premium · upgrade to view | |||
| David Varadi's Minimum Correlation Portfolio | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Sigma Pharmaceuticals Ltd’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Sigma Pharmaceuticals Ltd (Australia)
Sigma Pharmaceuticals Ltd is a listed security in Australia. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Scandinavian Investment Group A/S
Frequently asked questions
What is Sigma Pharmaceuticals Ltd?
What is the latest Sigma Pharmaceuticals Ltd price?
Is Sigma Pharmaceuticals Ltd in an uptrend?
How volatile is Sigma Pharmaceuticals Ltd?
What factors affect Sigma Pharmaceuticals Ltd?
Which trading strategies trade Sigma Pharmaceuticals Ltd?
How are Sigma Pharmaceuticals Ltd returns analysed?
Where can I download free Sigma Pharmaceuticals Ltd historical data?
Free Sigma Pharmaceuticals Ltd historical data (last 10 years)
Browse or instantly download the last 10 years of Sigma Pharmaceuticals Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.SIG.AU&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 2.89 |
| 2026-11-19 | 2.89 |
| 2026-11-18 | 2.9 |
| 2026-11-17 | 2.9 |
| 2026-11-16 | 2.9 |
| 2026-11-13 | 2.89 |
| 2026-11-12 | 2.89 |
| 2026-11-11 | 2.91 |
| 2026-11-10 | 2.87 |
| 2026-11-09 | 2.85 |
About this stock
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.